Hongxin Bio is an mRNA drug developer, focusing on nucleic acid drug delivery and RNA drug development.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 30, 2022 | Angel | — | 2 | Hongtao Capital | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Hongtao Capital | Yes | Angel |
Nanling Fund | — | Angel |